Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
|
V92854 | Alloc-Val-Ala-OH | 330970-70-2 | |
![]() |
V90215 | alpha-Hydroxy farnesyl phosphonic acid | 148796-53-6 | alpha-Hydroxy farnesyl phosphonic acid (Hydroxyfarnesyl phosphate) is a non-hydrolyzable analog of farnesyl pyrophosphate that acts as a competitive inhibitor of farnesyl transferase (FTase). |
|
V92853 | BOC-PHE-LEU-OH | 33014-68-5 | |
![]() |
V92589 | AlPhos Pd G6 Br | 2097600-15-0 | |
![]() |
V87290 | Aminoacyl tRNA synthetase-IN-3 | Aminoacyl tRNA synthetase-IN-3 (compound 36K3) is an inhibitor of lysine tRNA synthetase (PfLysRS) of Plasmodium falciparum (malaria parasite) (IC50=59.2 nM), which inhibits the activity of PfLysRS by occupying the ATP binding site and L-lysine binding site of PfLysRS. | |
![]() |
V92385 | Ammonium metavanadate, 99%(RT) | 7803-55-6 | Ammonium metavanadate, 99%(RT) (Ammonium vanadate(V), 99%(RT)) is an inorganic acid used as a catalyst in organic synthesis. |
![]() |
V89279 | Amphos | 932710-63-9 | Amphos is a biochemical reagent that can be used as a biomaterial or organic compound related to life science research. |
![]() |
V89282 | Anaritide | 95896-08-5 | Anaritide is a synthetic form of cardiac natriuretic peptide (ANP) composed of 25 amino acids. |
![]() |
V87325 | Anti-ANGPTL4 Antibody | Anti-ANGPTL4 Antibody is a CHO expressed human antibody targeting ANGPTL4. | |
![]() |
V87323 | Anti-ANGPTL8 Antibody | Anti-ANGPTL8 Antibody is a CHO expressed human antibody targeting ANGPTL8. | |
![]() |
V92051 | Anti-melanoma agent 3 | 1253697-49-2 | Anti-melanoma agent 3 (compound 5cb) is a 2-aryl-4-benzoyl-imidazole (ABI) derivative and an inhibitor of melanoma xenografts. |
![]() |
V89482 | Anticancer agent 200 | Anticancer agent 200 (6d) is a potential anticancer agent with antimetastatic activity. | |
![]() |
V89630 | Anticancer agent 208 | 894565-34-5 | Anticancer agent 208 (C014) is an anticancer agent that can be used to inhibit cancer or prevent cancer recurrence. |
![]() |
V89625 | Anticancer agent 209 | 545445-44-1 | Anticancer agent 209 is an anticancer agent. |
![]() |
V89558 | Anticancer agent 224 | Anticancer agent 224 (Compound 16) is an anticancer agent that can effectively inhibit the growth of central nervous system (CNS) cancer, renal cancer, and breast cancer cells with GI50 values ranging from 0. | |
![]() |
V88625 | Anticancer agent 230 | 2485052-87-5 | Anticancer agent 230 (example 65) is a caseinolytic protease P (ClpP) activator with anticancer activity. |
![]() |
V92043 | Anticancer agent 240 | 3039831-27-8 | Anticancer agent 240 (compound 9b) is an 8-quinolinesulfonamide derivative with cytotoxic activity. |
![]() |
V89368 | Anticancer agent 242 | Anticancer agent 242 (7) has anticancer activity against A2780 (IC50 = 0.24 μM, ovarian adenocarcinoma), A2780cis (IC50 = 0.45 μM, ovarian adenocarcinoma), CCD18Co (IC50 = 0.59 μM, non-malignant human fibroblasts), A549 (IC50 = 0.32 μM, lung adenocarcinoma), HT29 (IC50 = 0.26 μM colorectal adenocarcinoma), MCF7 (IC50 = 0.55 μM, breast adenocarcinoma). | |
![]() |
V92152 | Antifungal agent 107 | 2684411-12-7 | Antifungal agent 107 (compound b24) is an OSBP inhibitor with antifungal activity. |
![]() |
V91859 | Antiproliferative agent-52 | 2913194-20-2 | Antiproliferative agent-52 (Compound 4a) is an antiproliferative agent that exhibits good antiproliferative activity against four human tumor cell lines (A549, A2780, SKOV3, HCC827) with IC50 values ranging from 5.83-8.63 nM. |